Advanced Health Intelligence Dividendos y recompras

Dividendo controles de criterios 0/6

Advanced Health Intelligence no tiene historial de pago de dividendo.

Información clave

n/a

Rentabilidad por dividendo

-31.3%

Rendimiento de la recompra

Rendimiento total para el accionista	-31.3%
Rendimiento futuro de los dividendos	n/a
Crecimiento de los dividendos	n/a
Próxima fecha de pago de dividendos	n/a
Fecha ex dividendo	n/a
Dividendo por acción	n/a
Ratio de pago	n/a

Últimas actualizaciones de dividendos y recompras

No hay actualizaciones

Recent updates

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: No hay datos suficientes para determinar si los dividendos por acción de AHI han sido estables en el pasado.

Dividendo creciente: Datos insuficientes para determinar si los pagos de dividendos de AHI han aumentado.

Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Advanced Health Intelligence vs. Mercado

¿Cómo se compara la rentabilidad por dividendo de AHI con la del mercado?
Segmento	Rentabilidad por dividendo
Empresa (AHI)	n/a
Suelo de mercado 25% (AU)	2.6%
Techo de mercado 25% (AU)	6.0%
Media de la industria (Healthcare Services)	1.0%
Analista de previsiones (AHI) (hasta 3 años)	n/a

Dividendo destacado: No es posible evaluar la rentabilidad por dividendo de AHI en comparación con el 25% inferior de los pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Alto dividendo: No es posible evaluar la rentabilidad por dividendo de AHI en comparación con el 25% de los principales pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Pago de beneficios a los accionistas

Cobertura de los beneficios: No hay datos suficientes para calcular el ratio de pago de AHI para determinar si sus pagos de dividendos están cubiertos por los beneficios.

Pago en efectivo a los accionistas

Cobertura de flujo de caja: No es posible calcular la sostenibilidad de los dividendos, ya que AHI no ha comunicado ningún pago.

Advanced Health Intelligence Dividendos y recompras

Dividendo controles de criterios 0/6

Información clave

Últimas actualizaciones de dividendos y recompras

Recent updates

Advanced Health Intelligence Ltd, Annual General Meeting, Nov 29, 2024

Advanced Health Intelligence Ltd(NasdaqCM:AHI) dropped from NASDAQ Composite Index

Advanced Health Intelligence Ltd has filed a Follow-on Equity Offering in the amount of AUD 1.9575 million.

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.2 million.

Advanced Health Intelligence Ltd to Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million.

Advanced Health Intelligence Ltd. announced delayed 20-F filing

Advanced Health Intelligence Ltd., Annual General Meeting, Nov 17, 2023

Advanced Health Intelligence Ltd. announced that it has received AUD 1.5 million in funding

Full year 2023 earnings released: AU$0.072 loss per share (vs AU$0.13 loss in FY 2022)

New minor risk - Financial data availability

Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 5 million.

New major risk - Share price stability

First half 2023 earnings released: AU$0.024 loss per share (vs AU$0.10 loss in 1H 2022)

Forecast breakeven date pushed back to 2025

High number of new directors

Advanced Health Intelligence Ltd. Announces Board Changes

Advanced Human Imaging Limited (ASX:AHI) completed the acquisition of WellteQ Digital Health Inc. (CNSX:WTEQ).

Advanced Human Imaging Appoints Dr. Peter Vaughan as Non-Executive Director

Advanced Human Imaging Limited announced delayed 20-F filing

Advanced Human Imaging Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.11 loss in FY 2021)

Forecast breakeven date pushed back to 2025

Full year 2022 earnings released: AU$0.13 loss per share (vs AU$0.11 loss in FY 2021)

Advanced Human Imaging Limited (ASX:AHI) executed a non-binding letter of intent to acquire WellteQ Digital Health Inc. (CNSX:WTEQ) for AUD 4.3 million.

Advanced Human Imaging Ltd Appoints Peter Goldstein as Non-Executive Director

Advanced Human Imaging Limited to Be Deleted from Other OTC

Advanced Human Imaging Limited Announces Resignation of Edward Greissing Jr as Director

Does Advanced Human Imaging (ASX:AHI) Have A Healthy Balance Sheet?

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Forecast to breakeven in 2023

Advanced Human Imaging Limited Appoints Dr. Katherine Iscoe as Director

Advanced Human Imaging Limited Announces Executive Changes

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces the Submission of the Health Cube App into the Top 10 China App Stores with Tinjoy Biotech Limited

No independent directors

No independent directors

No independent directors

No independent directors

No independent directors

Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020)

Advanced Human Imaging Limited Announces Derma AI Embedded in the AHI DermaScan Receives CE Mark Clearance in the European Union for the Dermatology AI Component in CompleteScan

Advanced Human Imaging's DermaScan AI Receives Medical Device Approval 27 EU Countries (CE Mark)

Advanced Human Imaging Limited to Launch BodyScan in Original Fit Factory's Fitness App Truconnect to Audience of 150+ Million

Advanced Human Imaging (ASX:AHI) Has Debt But No Earnings; Should You Worry?

New 90-day high: AU$2.17

First half 2021 earnings released: AU$0.046 loss per share (vs AU$0.029 loss in 1H 2020)

What We Learned About MyFiziq's (ASX:MYQ) CEO Compensation

MyFiziq Limited to Appoint New US Board Members in Readiness for Nasdaq

MyFiziq Names William Bradford as New Global Chief Business Officer in USA

New 90-day high: AU$1.35

How Many MyFiziq Limited (ASX:MYQ) Shares Have Insiders Sold, In The Last Year?

MyFiziq Signs Marketing and Expansion Agreement with Bearn

MyFiziq Limited Announces Management Changes

Myfiziq Limited Releases Applications with Biomorphik Pty Ltd App with the Myfiziq Technology

Do Insiders Own Lots Of Shares In MyFiziq Limited (ASX:MYQ)?

MyFiziq Limited Completes Definitive Agreements with MVMNT Inc

MyFiziq Limited announced that it expects to receive AUD 5 million in funding

MyFiziq Limited Signs Binding Term Sheet with Jayex Healthcare Limited

Myfiziq Limited Signs Agreement with Nexus-Vita with USD 3.5 Million Guarantee

MyFiziq Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.052 loss per share

New 90-day high: AU$1.32

MyFiziq Limited Signs Definitive Agreements with Biomorphik to Accelerate A November 2020 Release

New 90-day high - AU$0.61

Full year earnings released - AU$0.052 loss per share

New 90-day high - AU$0.32

Estabilidad y crecimiento de los pagos

Rentabilidad por dividendo vs. Mercado

Pago de beneficios a los accionistas

Pago en efectivo a los accionistas

Descubre empresas que pagan buenos dividendos